ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 485 out of 6645

$512K Total Retail Price of All Prescriptions

Rank: 1124 out of 6645

575 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 575 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 575 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 11,552 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 609 539 1 3
AMLODIPINE BESYLATE 471 455 2 2
LOVASTATIN 445 439 3 15
OMEPRAZOLE 422 373 4 6
LEVOTHYROXINE SODIUM 388 342 5 4
FUROSEMIDE 325 313 6 11
DIOVAN 323 296 7 19
TAMSULOSIN HCL 275 231 8 22
SIMVASTATIN 275 246 8 1
LOSARTAN POTASSIUM 269 262 10 12
ATENOLOL 263 254 11 8
METFORMIN HCL 252 221 12 7
GABAPENTIN 248 193 13 18
HYDROCODONE-ACETAMINOPHEN 242 210 S3 14 5
CARVEDILOL 241 203 15 25
GLYBURIDE 224 218 R 16 58
ZOLPIDEM TARTRATE 217 185 17 17
POTASSIUM CHLORIDE 203 178 18 28
FINASTERIDE 179 169 19 73
CLOPIDOGREL 166 162 20 36
PRAVASTATIN SODIUM 158 116 21 20
BENAZEPRIL HCL 149 139 22 21
METOPROLOL TARTRATE 140 140 23 13
PANTOPRAZOLE SODIUM 137 123 24 29
ALPRAZOLAM 136 136 25 195
IBUPROFEN 135 107 26 42
LOSARTAN-HYDROCHLOROTHIAZIDE 133 106 27 62
TRIAMTERENE-HCTZ 128 128 28 52
TERAZOSIN HCL 127 127 29 48
NIFEDIPINE ER 127 112 29 82
CLONIDINE HCL 124 107 31 56
DIGOXIN 119 119 32 59
GLIPIZIDE 114 99 33 23
PLAVIX 113 112 34 49
VERAPAMIL ER 104 104 35 154
DONEPEZIL HCL 96 96 36 27
ATORVASTATIN CALCIUM 94 87 37 10
ISOSORBIDE MONONITRATE ER 92 92 38 66
HYDROCHLOROTHIAZIDE 91 90 39 9
PROAIR HFA 81 75 40 32
RANITIDINE HCL 78 71 41 51
FLUTICASONE PROPIONATE 78 68 41 26
METOPROLOL SUCCINATE 77 73 43 24
SERTRALINE HCL 73 72 44 43
CLOBETASOL PROPIONATE 71 66 45 228
INSULIN SYRINGE 71 60 45 61
DIOVAN HCT 68 63 47 64
OXYBUTYNIN CHLORIDE 65 63 48 129
CIPROFLOXACIN HCL 62 59 49 67
DILTIAZEM 24HR ER 62 62 49 187
ALENDRONATE SODIUM 58 58 51 14
AMOX TR-POTASSIUM CLAVULANATE 56 54 52 185
PROPRANOLOL HCL 54 49 53 151
MECLIZINE HCL 54 54 53 122
TRAMADOL HCL 53 49 55 30
FELODIPINE ER 52 40 56 105
CLOTRIMAZOLE-BETAMETHASONE 51 47 57 177
TEMAZEPAM 51 51 57 269
LEVOXYL 50 49 59 136
ROPINIROLE HCL 50 37 59 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.